Keywords: hana, biosci, loss, deepens, 10m, biosciences, usa-based

Hana Biosci's loss for 2005 deepens to $10M

Article | 27 March 2006

Print This

Hana Biosciences, a USA-based biopharmaceutical company focused on cancer, reported a net loss of $10.0 million, or $0.57 per share, for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in